Nawaloka Hospitals PLC (COSE: NHL.N0000)
Sri Lanka
· Delayed Price · Currency is LKR 3.600
-0.100 (-2.70%)
At close: Sep 9, 2024
Nawaloka Hospitals Income Statement
Financials in millions LKR. Fiscal year is April - March.
Millions LKR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 10,680 | 10,648 | 9,305 | 15,302 | 11,828 | 9,036 | Upgrade
|
| Revenue Growth (YoY) | 9.35% | 14.44% | -39.19% | 29.38% | 30.90% | 5.88% | Upgrade
|
| Cost of Revenue | 4,935 | 4,820 | 4,670 | 7,461 | 6,285 | 4,248 | Upgrade
|
| Gross Profit | 5,745 | 5,828 | 4,635 | 7,841 | 5,542 | 4,788 | Upgrade
|
| Selling, General & Admin | 4,302 | 4,218 | 3,860 | 4,856 | 3,753 | 3,635 | Upgrade
|
| Other Operating Expenses | 0.06 | 8.22 | 258.91 | 232.59 | -37.37 | -61.96 | Upgrade
|
| Operating Expenses | 4,302 | 4,227 | 4,709 | 5,927 | 4,042 | 3,625 | Upgrade
|
| Operating Income | 1,443 | 1,601 | -73.46 | 1,914 | 1,501 | 1,163 | Upgrade
|
| Interest Expense | -1,151 | -1,389 | -1,951 | -1,035 | -1,162 | -1,335 | Upgrade
|
| Interest & Investment Income | 36.91 | 30.82 | 58.58 | 53.46 | 48.27 | 44.17 | Upgrade
|
| Earnings From Equity Investments | 309.99 | 309.99 | 159.89 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | -102.56 | -215 | -24.4 | -25.72 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.21 | -0.21 | -2.08 | -7.64 | -18.03 | -29.41 | Upgrade
|
| EBT Excluding Unusual Items | 638.47 | 552.69 | -1,911 | 709.67 | 344.61 | -182.87 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | -253.66 | 2.57 | 16.61 | Upgrade
|
| Pretax Income | 638.47 | 552.69 | -1,911 | 456.02 | 347.17 | -166.26 | Upgrade
|
| Income Tax Expense | 287.16 | 204.93 | 527.67 | 552.61 | -154.09 | -182.24 | Upgrade
|
| Net Income | 351.31 | 347.77 | -2,438 | -96.59 | 501.26 | 15.98 | Upgrade
|
| Net Income to Common | 351.31 | 347.77 | -2,438 | -96.59 | 501.26 | 15.98 | Upgrade
|
| Net Income Growth | - | - | - | - | 3036.68% | - | Upgrade
|
| Shares Outstanding (Basic) | 1,401 | 1,391 | 1,410 | 1,410 | 1,410 | 1,410 | Upgrade
|
| Shares Outstanding (Diluted) | 1,401 | 1,391 | 1,410 | 1,410 | 1,410 | 1,410 | Upgrade
|
| Shares Change (YoY) | 0.36% | -1.31% | - | - | - | - | Upgrade
|
| EPS (Basic) | 0.25 | 0.25 | -1.73 | -0.07 | 0.36 | 0.01 | Upgrade
|
| EPS (Diluted) | 0.25 | 0.25 | -1.73 | -0.07 | 0.36 | 0.01 | Upgrade
|
| EPS Growth | - | - | - | - | 3456.31% | - | Upgrade
|
| Free Cash Flow | 568.99 | 774.9 | 1,552 | 1,259 | -65.36 | -310.77 | Upgrade
|
| Free Cash Flow Per Share | 0.41 | 0.56 | 1.10 | 0.89 | -0.05 | -0.22 | Upgrade
|
| Gross Margin | 53.79% | 54.73% | 49.81% | 51.24% | 46.86% | 52.99% | Upgrade
|
| Operating Margin | 13.51% | 15.04% | -0.79% | 12.51% | 12.69% | 12.87% | Upgrade
|
| Profit Margin | 3.29% | 3.27% | -26.21% | -0.63% | 4.24% | 0.18% | Upgrade
|
| Free Cash Flow Margin | 5.33% | 7.28% | 16.68% | 8.23% | -0.55% | -3.44% | Upgrade
|
| EBITDA | 2,311 | 2,449 | 754.97 | 2,744 | 2,329 | 1,996 | Upgrade
|
| EBITDA Margin | 21.64% | 23.00% | 8.11% | 17.93% | 19.69% | 22.09% | Upgrade
|
| D&A For EBITDA | 868.03 | 848.05 | 828.43 | 830.28 | 828.33 | 832.56 | Upgrade
|
| EBIT | 1,443 | 1,601 | -73.46 | 1,914 | 1,501 | 1,163 | Upgrade
|
| EBIT Margin | 13.51% | 15.04% | -0.79% | 12.51% | 12.69% | 12.87% | Upgrade
|
| Effective Tax Rate | 44.98% | 37.08% | - | 121.18% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.